This research develops an AI model that combines thyroid ultrasound imaging with genetic testing to improve diagnosis of indeterminate thyroid nodules. By integrating molecular and imaging data, the model helps distinguish benign from cancerous nodules more accurately, reducing unnecessary surgeries and improving clinical decision-making for thyroid cancer patients.

This research develops an affordable, rapid genetic testing system to personalize antidepressant treatment. By detecting DNA mutations that affect drug metabolism, the technology helps doctors prescribe the right medication for each patient. The goal is to reduce ineffective treatments and improve mental health care—especially for veterans struggling with PTSD and depression.